https://ift.tt/2wwdHAe Alzheimer’s Drug Poses a Dilemma for the F.D.A. Alzheimer's Disease, Drugs (Pharmaceuticals), Clinical Trials, Elderly, Memory, Brain, your-feed-science, your-feed-healthcare If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say there isn’t enough evidence it works. BY PAM BELLUCK AND REBECCA ROBBINS https://ift.tt/3cjMX8L June 6, 2021 at 12:30AM